Entrada Therapeutics, Inc. · NASDAQ:TRDA

T. Rowe Price Associates Inc's stake in Entrada Therapeutics, Inc. fell to 0.90% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

T. Rowe Price Associates Inc's stake in Entrada Therapeutics, Inc. fell to 0.90%, 360,526 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
0.90%
Shares
360,526
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.0.90%360,526

Source

View original at SEC

Related